Promising lymphoma therapy trial halted after just one patient
Disease control
Terminated
This early-phase trial tested a two-step radiation treatment for people with non-Hodgkin lymphoma that had come back or stopped responding to standard therapies. Only one person took part before the study was stopped. The goal was to find a safe dose and see if the treatment coul…
Phase: PHASE1 • Sponsor: Y-mAbs Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC